Virobay, Inc. Executive Officer Annual Base Salary Approval (2014)
Virobay, Inc.'s Board of Directors approved new annual base salaries for its executive officers, effective immediately upon the closing of the company's initial public offering. The agreement lists the names, titles, and corresponding annual salaries for four key executives, including the President and CEO, Chief Financial and Accounting Officer, Chief Medical Officer, and Vice President of Chemistry, Manufacturing and Controls. This document formalizes the compensation terms for these officers as part of their employment with the company.
Exhibit 10.21
Executive Officer Annual Base Salaries
On September 12, 2014, at a meeting of the Board of Directors (the “Board”) of Virobay, Inc. (the “Company”), the Board approved annualized base salaries for the Company’s executive officers and certain employees as set forth below. The annualized base salaries are effective immediately as of the closing of the Company’s initial public offering.
| Name | Title | Annualized Base Salary | ||||
| Robert F. Booth, Ph. D. | President and Chief Executive Officer | $ | 415,000 | |||
| James H. Welch | Chief Financial and Accounting Officer, Secretary and Compliance Officer | $ | 300,000 | |||
| David B. Karpf, M.D. | Chief Medical Officer | $ | 320,000 | |||
| Anantha R. Sudhakar, Ph.D. | Vice President, Chemistry, Manufacturing and Controls | $ | 265,000 | |||
